An oral liquid formulation including an effective amount of loratadine, or a pharmaceutically acceptable salt or metabolite thereof; and a pharmaceutically acceptable carrier including a mono- or poly-hydroxy phenol component, a solubilizing agent and a chelating agent. Methods of preparing and administering such formulations are also included.
申请公布号
WO2007143382(A3)
申请公布日期
2008.01.31
申请号
WO2007US69360
申请日期
2007.05.21
申请人
MORTON GROVE PHARMACEUTICALS, INC.;DAGAR, APARNA;GUDI, SIVARAMAPRASAD;OPAWALE, FOYEKE